About This Stock More About This StockReadReadReadReadRead
Merck KGaA And Pfizer Get FDA Approval Of Checkpoint Inhibitor "Avelumab" For Rare Merkel Cell Skin Cancer Therapy
Article By: Tarun Chandra, CFA
Tuesday, March 14, 2017 11:00 PM EDT
Biotech sector is poised for further gains this year after a strong start. The nomination of an industry-favored FDA head is a positive. There is a possibility of receiving some clarity soon on Medicare price negotiation issue as well.
Article By: E.B. Capital Markets
Monday, March 13, 2017 2:01 PM EDT
The average ADR in our universe rallied 0.77% last week and is trading -14.86% below its 52 week high, 4.05% above its 200 dma, and has 3 days to cover held short.
In this article: ASR, ASX, AZN, BMO, BP, CEA, CNQ, CS, CUK, LUX, NOAH, RY, TEO, TV, UMC, WBK, DASTY, MXCYY, NABZY, CTRP, OIIM, GGAL, AVDL
Article By: Arpita Dutt
Friday, March 10, 2017 9:17 AM EDT
Despite many twists and turns, the U.S. stock market has had a stupendous run since it reached a bottom in Mar 2009. The bull run has continued for eight years with the S&P 500 gaining 198.1% during this period.